Sonalis Consumer (SONALIS) Q2 FY27 Profit Crashes 83% as Revenue Slumps to a Two-Year Low
The nutrition bar maker's quarterly profit fell sharply as sales dropped 36% from last year, with cash flow remaining under pressure.
Sonalis Consumer Products reported a steep 83% quarterly drop in profit as revenue fell to its lowest level in two years. The company's cash flow remains negative, highlighting the strain of its ambitious expansion plans.
Sonalis Consumer Products is navigating a sharp contraction after a period of rapid growth. The nutrition bar maker's second quarter saw revenue fall to a two-year low and profit nearly evaporate, underscoring the volatility of its scaling journey and the cash demands of its ambitious diversification.
Revenue for the quarter ended September 2026 was ₹56 crore, down 36% from the same period last year and 10% from the previous quarter. Profit after tax fell even more sharply, dropping 83% sequentially to just ₹1 crore. The net profit margin compressed to 1.8%, a steep decline from 9.7% in the March 2026 quarter.
Revenue & profit
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin
| Metric | CurrentQ2 FY27 | Same quarter LYQ2 FY26 |
|---|---|---|
| Revenue (₹ Cr) | 56.0YoY -36% | 88.0 |
| Profit (₹ Cr) | 1.0YoY -50% | 2.0 |
| Net Profit Margin | 1.8%YoY -22% | 2.3% |
The cash cost of growth
The profit squeeze is not just an earnings story. Data from FlashFinance shows cash flow from operations was negative ₹0.4 crore for the first half of FY27, continuing a trend from the full prior year. This points to a fundamental strain: the company is growing its asset base faster than it generates cash from sales.
A key factor is a shift in working capital financing. Analysis by StockFin.ai notes a sharp drop in trade payables alongside rising short-term borrowings. This suggests Sonalis is moving from informal supplier credit to more formal—and potentially more costly—financing as it scales, pressuring near-term liquidity.
An ambitious pivot ahead
Despite the weak quarter, management's focus remains firmly on a transformative expansion. According to a StockFin.ai report, the company is in a strategic growth phase, aiming to diversify beyond nutrition bars into dairy and agro-products. It has plans to acquire a dairy business and establish a subsidiary in the UAE.
The ambition is vast. Reports from Tijori Finance and Arthneeti cite a company target of reaching ₹800 crore in revenue by 2028. However, this hinges on a critical near-term event: the renewal of its manufacturing license by December 2027. Tijori Finance suggests a delay of over six months could knock ₹20–25 crore off the FY28 revenue target.
Key Points
- Quarterly profit crashed 83% sequentially to ₹1 crore as revenue fell to a two-year low of ₹56 crore.
- Cash flow from operations remained negative, highlighting working capital strain as the company shifts from supplier credit to formal financing.
- Management is pursuing an aggressive diversification into dairy and international markets, targeting ₹800 crore revenue by 2028.
- A key binary risk is the renewal of the company's manufacturing license, due by December 2027.
Hexa Perspective
This quarter reveals the tension between Sonalis's high-growth narrative and its current operational reality. The company has successfully scaled revenue in the past, but the latest numbers show how quickly that momentum can reverse, with profitability highly sensitive to sales volume.
The negative cash flow is a more persistent concern than a quarterly earnings miss. It signals that the capital required for its ambitious dairy and warehousing expansions is being funded by the business itself, leaving little buffer. Investors are now weighing a promising long-term diversification story against a still-small profit base, strained liquidity, and a looming regulatory deadline that could disrupt the entire plan.
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.